CPT® Code 81538

1. Indications

The CPT® Code 81538 is indicated for use in patients diagnosed with lung cancer. The test is performed to assess the prognostic and predictive outcomes related to overall survival based on the levels of specific proteins in the serum. The following conditions and symptoms may warrant the use of this test:

• Lung Cancer Diagnosis Patients who have been diagnosed with lung cancer and require further evaluation of their prognosis.
• Prognostic Assessment Individuals needing a prognostic assessment to determine the likelihood of overall survival based on serum protein levels.
• Monitoring Treatment Response Patients undergoing treatment for lung cancer who may benefit from monitoring changes in serum protein levels over time.

2. Procedure

The procedure for CPT® Code 81538 involves several key steps to ensure accurate analysis of the serum proteins. The following outlines the procedural steps:

• Step 1: Sample Collection A blood sample is collected from the patient diagnosed with lung cancer. This sample is processed to obtain serum, which is the component of blood that contains the proteins of interest.
• Step 2: Protein Analysis The serum is subjected to advanced mass spectrometry techniques, specifically either surface-enhanced laser desorption/ionization – time of flight mass spectrometry (SELDI-TOF-MS) or matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). These methods allow for the identification and quantification of the eight specific proteins associated with lung cancer.
• Step 3: Data Comparison The spectral peaks obtained from the mass spectrometry analysis are compared to those from a normal control group. This comparison helps to identify any relative increases or decreases in the levels of the eight proteins.
• Step 4: Algorithm Score Calculation Based on the relative changes in protein levels, an algorithm score is calculated. This score categorizes the patient’s prognosis into two groups: good overall survival (≥5 years) or poor overall survival (<5 years).

3. Post-Procedure

After the procedure, the results of the protein analysis and the corresponding algorithm score are reported to the healthcare provider. This information is critical for guiding treatment decisions and patient management strategies. Patients may require follow-up consultations to discuss the implications of the test results and to determine the next steps in their care plan. Additionally, ongoing monitoring of serum protein levels may be recommended to assess treatment response and adjust therapeutic approaches as necessary.